TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive PDQ Used Mainly For Information To Public, Not Much By Non-Oncologists, Evaluation Finds August 18, 1989
TCL Archive Bypass Budget For FY Seeks $1.189 Billion, Would Fund 1,018 Competing Grants, Restore Cuts May 20, 1983
